| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/13/2005 | EP1229782A4 Pathogen tolerance genes |
| 04/13/2005 | EP1183353B1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 04/13/2005 | EP1180153B1 Phage-dependent super-production of biologically active proteins and peptides |
| 04/13/2005 | EP1074624B1 Attenuated chicken-pox virus oka strain gene 62 and method for identifying virus strain for attenuated live chicken-pox vaccine by using the gene |
| 04/13/2005 | EP1021462A4 Assays for nuclear receptor ligands using fret |
| 04/13/2005 | EP0956052B1 Chimeric retrovirus/adenovirus system |
| 04/13/2005 | EP0938555B1 Constructs and complexes of cyclin e |
| 04/13/2005 | EP0871737B1 Method of protecting crop plants against insect pests |
| 04/13/2005 | EP0857217B1 Novel expression vectors and methods of use |
| 04/13/2005 | EP0774971B1 Synthetic peptide inhibitors of hiv transmission |
| 04/13/2005 | EP0741782B1 Methods using eaa3 or eaa4 receptors |
| 04/13/2005 | CN1606625A HIV-1 subtype isolate regulatory/accessory genes, and modifications and derivatives thereof |
| 04/13/2005 | CN1606624A Vaccines |
| 04/13/2005 | CN1606617A Alleles of the siga gene from coryneform bacteria |
| 04/13/2005 | CN1606615A Method for expanding hematopoietic stem cells |
| 04/13/2005 | CN1606570A A fusion protein suitable to highly effective expression and production method thereof |
| 04/13/2005 | CN1606568A Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 04/13/2005 | CN1606567A Antimicrobial polypeptides from pseudoplectania nigrella |
| 04/13/2005 | CN1606565A Nucleic acids encoding recominant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 04/13/2005 | CN1606564A Modular peptide-based reagent |
| 04/13/2005 | CN1606452A Liquid composition of modified factor vii polypeptides |
| 04/13/2005 | CN1606451A Remedies and/or preventives for conformational diseases |
| 04/13/2005 | CN1606450A Polypeptide, the conjugate thereof with doxorubicin and a pharmaceutical composition based thereon |
| 04/13/2005 | CN1605592A Protease resistant mutein of human ciliary neurotrophic factor and its preparation and use |
| 04/13/2005 | CN1605591A Labelled molecule capable of identifying reactive astrocytes and use thereof |
| 04/13/2005 | CN1196797C Diagnostics and therapeutics for glaucoma |
| 04/13/2005 | CN1196794C Antiseptic WAP-8294A and WAP-8294AX and their prepn process and antiseptic composition |
| 04/13/2005 | CN1196792C New escherichia coli host/vector system based on antibiotic free selection by conplementation of auxotrophy |
| 04/13/2005 | CN1196791C Psudomonas exotoxin-myelin basic protein chimeric proteins |
| 04/13/2005 | CN1196788C Assembly of wild-type and chimeric influenza virus-like particles (VLPS) |
| 04/13/2005 | CN1196787C Virulence genes and proteins and their use |
| 04/13/2005 | CN1196786C Methods for preventing graft rejection in transplantation and for producing universal gene therapy host cell |
| 04/13/2005 | CN1196785C Beta-amyloid peptdie-binding proteins and polynucleotides encoding the same |
| 04/13/2005 | CN1196784C Promoter of human endoglin gene and its use |
| 04/13/2005 | CN1196713C Process for preparing cross-linked haematoglobin as substitute of red blood cell |
| 04/13/2005 | CN1196712C Human like collagen and production method thereof |
| 04/13/2005 | CN1196495C Mutant human CD80 and compositions and methods of making and using the same |
| 04/12/2005 | US6878860 Comprises antisense nucleotides sequences transformed and expressed in tomato for controlling flowering; gene expression inhibition and tissue engineering |
| 04/12/2005 | US6878858 Animal model for use as tool in the diagnosis and treatment of nervous system disorders |
| 04/12/2005 | US6878817 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 04/12/2005 | US6878816 Vmp-like sequences of pathogenic Borrelia |
| 04/12/2005 | US6878813 Elastase-resistant antithrombin III (ATIII) for treating blood clotting disorders |
| 04/12/2005 | US6878812 Nucleotide sequences coding enzymatic polypeptide for use in treatment of inflammation and cancer |
| 04/12/2005 | US6878811 Substance with antithrombotic activity and method for detecting glycokallidin |
| 04/12/2005 | US6878809 Rad23 genes and uses thereof |
| 04/12/2005 | US6878808 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof |
| 04/12/2005 | US6878807 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/12/2005 | US6878806 Human secreted protein HTEEB42 |
| 04/12/2005 | US6878805 Peptide-conjugated oligomeric compounds |
| 04/12/2005 | US6878804 Coupling a solid support derived from polystyrene crosslinked with divinylbenzene which is functionalized by 2-chlrotrityl linker with an N-protected derivatives of preferential amino acid |
| 04/12/2005 | US6878692 Nucleotide sequences coding apoptosis protein for use in the treatment of autoimmune diseases and cancer |
| 04/12/2005 | US6878687 Activates the interferon-sensitive responsive promoter element. |
| 04/12/2005 | US6878685 Purified Tat and Nef to promote localized accumulation of CD4+ cells, and an antimicrobial chemotherapeutic agent, such as an antibiotic; may also contain tumor necrosis factor-alpha |
| 04/12/2005 | US6878549 Generating expression vector for use as gene transfer tool |
| 04/12/2005 | US6878542 Using fluorescence-activated cell sorting to separate and recover mammlian progenitor cells |
| 04/12/2005 | US6878536 Phosphoriboxyl-pyrophosphate synthetase polypeptide |
| 04/12/2005 | US6878528 Polynucleotides encoding a mammalian Langerhans cell antigen |
| 04/12/2005 | US6878527 Modified proteins |
| 04/12/2005 | US6878526 Treating cancer |
| 04/12/2005 | US6878525 Peptide leukotriene receptor |
| 04/12/2005 | US6878520 C-terminal region of agouti-related transcript (ART) protein |
| 04/12/2005 | US6878376 Modulate immunology response |
| 04/12/2005 | US6878375 HA-1 antigen |
| 04/12/2005 | US6878372 Methods of preventing and treating flavivirus infection in animals |
| 04/12/2005 | US6878370 Chemically modified TNF-α |
| 04/12/2005 | CA2332628C Seed-preferred promoters |
| 04/12/2005 | CA2250704C Glial cell line-derived neurotrophic factor receptor |
| 04/12/2005 | CA2214665C Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same |
| 04/12/2005 | CA2123363C Lysosomal enzyme-cleavable antitumor drug conjugates |
| 04/12/2005 | CA2113813C Immunoglobulin variants for specific fc epsilon receptors |
| 04/12/2005 | CA2108292C Process for preparing hepatitis a (hav) antigens and vaccines |
| 04/12/2005 | CA2086672C Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 04/12/2005 | CA2074825C Chimeric chains for receptor-associated signal transduction pathways |
| 04/12/2005 | CA1341479C Hybrid single-chain plasminogen activators |
| 04/08/2005 | CA2445743A1 Methods for modulating neuronal responses |
| 04/07/2005 | WO2005031362A2 Novel antibacterial agents and methods of identifying and utilizing same |
| 04/07/2005 | WO2005031310A2 Fractal-forming alkylketene dimers for integral membrane protein crystal growth |
| 04/07/2005 | WO2005031001A2 Novel therapeutic targets in cancer |
| 04/07/2005 | WO2005030994A1 Cells and methods useful in characterising the immunotoxic activity of xenobiotic substances |
| 04/07/2005 | WO2005030988A1 Method of predicting and/or modifying conversion potential of embryogenic tissues of plants |
| 04/07/2005 | WO2005030970A2 Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances |
| 04/07/2005 | WO2005030969A1 Method for mass production of human follicle stimulating hormone |
| 04/07/2005 | WO2005030967A2 Crop plant cystatin proteinase inhibitors and methods of use |
| 04/07/2005 | WO2005030965A2 Expansin polypeptides |
| 04/07/2005 | WO2005030964A1 Hiv pharmaccines |
| 04/07/2005 | WO2005030963A1 Leader sequences for use in production of proteins |
| 04/07/2005 | WO2005030956A1 METHOD OF CLEAVING POLYPEPTIDE BY USING OmpT PROTEASE MUTANT |
| 04/07/2005 | WO2005030955A1 Protein expressed in nk cell |
| 04/07/2005 | WO2005030954A1 Process for producing antigenic substance |
| 04/07/2005 | WO2005030951A1 Royal jelly peptide and composition containing the same |
| 04/07/2005 | WO2005030950A1 Transporter participating in the absorption and transportation of complex of metal such as iron in rice and gene thereof |
| 04/07/2005 | WO2005030943A1 Isolated nucleic acid molecules from the genome of citrus sudden death virus and uses thereof |
| 04/07/2005 | WO2005030939A2 Method and composition for regulating expansion of stem cells |
| 04/07/2005 | WO2005030930A2 Variants of cyan fluorescent protein with improved fluorescent properties |
| 04/07/2005 | WO2005030928A2 PORCINE INVARIANT CHAIN PROTEIN, FULL LENGTH cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION |
| 04/07/2005 | WO2005030806A2 Norovirus monoclonal antibodies and peptides |
| 04/07/2005 | WO2005030805A1 Novel protein complex and use thereof |
| 04/07/2005 | WO2005030804A2 A method of modulating cell survival, differentiation and/or synaptic plasticity |
| 04/07/2005 | WO2005030803A1 Therapeutic molecules |
| 04/07/2005 | WO2005030802A2 Antigens for an east coast fever vaccine |